(Total Views: 471)
Posted On: 08/08/2025 11:16:06 PM
Post# of 155729
I have read in our patent applications & patents, 13 to 38 weeks for Leronlimab to fully occupy CCR5 receptors. Of course each under different conditions.
In comparison to what have read, with mTNBC having shown significant upregulated in 30 - 90 days, that is medically super quick. No surprise too given the total package Leronlimab brings to bear on the mTNBC tumor environment.
Including a single LL dose doubled the mOS in CRC poster.
CRC trial will be phenomenal..
Very good odds of early stoppage.
In comparison to what have read, with mTNBC having shown significant upregulated in 30 - 90 days, that is medically super quick. No surprise too given the total package Leronlimab brings to bear on the mTNBC tumor environment.
Including a single LL dose doubled the mOS in CRC poster.
CRC trial will be phenomenal..
Very good odds of early stoppage.
(7)
(0)
